4 completed, 2 terminated. 4 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 4 | 1 | Terminated 1 |
Follow Complex Partial Seizures: new trials by email Literature Review of Complex Partial Seizures trials Research Report on Complex Partial Seizures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra Cranial EEG Activity During Dexmedetomidine Sedation EEG Recording - Complex Partial Seizures | Terminated | University Health Network, Toronto | 5 | 2012-07-01 | 2022-12-22 | |
| Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures Remegal - Epilepsy, Simple Partial Seizures | Phase 3 | Completed | Valexfarm | 224 | 2012-03-01 | 2017-05-11 |
| Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients vigabatrin - Complex Partial Seizures | Phase 4 | Terminated | University of Pennsylvania | 1 | 2010-08-01 | 2017-07-12 |
| An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. carisbamate - Epilepsy, Complex Partial Seizures | Phase 3 | Completed | SK Life Science, Inc. | 991 | 2007-02-01 | 2013-06-18 |
| A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. RWJ-333369 - Epilepsy, Epilepsy, Focal | Phase 3 | Completed | SK Life Science, Inc. | 563 | 2006-11-01 | 2012-06-18 |
| A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. RWJ-333369 - Epilepsy, Epilepsy, Focal | Phase 3 | Completed | SK Life Science, Inc. | 566 | 2006-11-01 | 2012-06-20 |
Seizures (6) · Epilepsies, Partial (4) · Epilepsy (4) · Epilepsy, Complex Partial (3) · Tuberous Sclerosis (1)
Nervous System Diseases (6) · Neurologic Manifestations (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Brain Diseases (4) · Central Nervous System Diseases (4) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Neoplasms (1) · Neoplasms, Multiple Primary (1)
S-2-O-carbamoyl-1-o-chlorophenyl-ethanol (3) · Vigabatrin (1)
SK Life Science, Inc. (3) · University Health Network, Toronto (1) · University of Pennsylvania (1) · Valexfarm (1)
Canada (1) · Russia (1) · United States (1)
John Pollard, MD (1)